“Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b/3, Double-Blind, Placebo-Controlled Study” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s103. doi:10.25251/skin.6.supp.103.